127 related articles for article (PubMed ID: 26205499)
21. PAQR3 plays a suppressive role in laryngeal squamous cell carcinoma.
Wu Q; Zhuang K; Li H
Tumour Biol; 2016 Jan; 37(1):561-5. PubMed ID: 26232324
[TBL] [Abstract][Full Text] [Related]
22. Cellular concentrations of DDB2 regulate dynamic binding of DDB1 at UV-induced DNA damage.
Alekseev S; Luijsterburg MS; Pines A; Geverts B; Mari PO; Giglia-Mari G; Lans H; Houtsmuller AB; Mullenders LH; Hoeijmakers JH; Vermeulen W
Mol Cell Biol; 2008 Dec; 28(24):7402-13. PubMed ID: 18936169
[TBL] [Abstract][Full Text] [Related]
23. Identification of an adaptor protein that facilitates Nrf2-Keap1 complex formation and modulates antioxidant response.
Zhang Y; Hou Y; Liu C; Li Y; Guo W; Wu JL; Xu D; You X; Pan Y; Chen Y
Free Radic Biol Med; 2016 Aug; 97():38-49. PubMed ID: 27212020
[TBL] [Abstract][Full Text] [Related]
24. PAQR3 overexpression suppresses the aggressive phenotype of esophageal squamous cell carcinoma cells via inhibition of ERK signaling.
Bai G; Chu J; Eli M; Bao Y; Wen H
Biomed Pharmacother; 2017 Oct; 94():813-819. PubMed ID: 28802234
[TBL] [Abstract][Full Text] [Related]
25. Xeroderma pigmentosum complementation group E protein (XPE/DDB2): purification of various complexes of XPE and analyses of their damaged DNA binding and putative DNA repair properties.
Kulaksiz G; Reardon JT; Sancar A
Mol Cell Biol; 2005 Nov; 25(22):9784-92. PubMed ID: 16260596
[TBL] [Abstract][Full Text] [Related]
26. PAQR3 expression is downregulated in human breast cancers and correlated with HER2 expression.
Li Z; Ling ZQ; Guo W; Lu XX; Pan Y; Wang Z; Chen Y
Oncotarget; 2015 May; 6(14):12357-68. PubMed ID: 25900239
[TBL] [Abstract][Full Text] [Related]
27. Regulation of liver receptor homologue-1 by DDB2 E3 ligase activity is critical for hepatic glucose metabolism.
Lai TC; Hu MC
Sci Rep; 2019 Mar; 9(1):5304. PubMed ID: 30923324
[TBL] [Abstract][Full Text] [Related]
28. The deubiquitinating protein USP24 interacts with DDB2 and regulates DDB2 stability.
Zhang L; Lubin A; Chen H; Sun Z; Gong F
Cell Cycle; 2012 Dec; 11(23):4378-84. PubMed ID: 23159851
[TBL] [Abstract][Full Text] [Related]
29. Identification of PAQR3 as a new candidate tumor suppressor in hepatocellular carcinoma.
Wu HG; Zhang WJ; Ding Q; Peng G; Zou ZW; Liu T; Cao RB; Fei SJ; Li PC; Yang KY; Hu JL; Dai XF; Wu G; Li PD
Oncol Rep; 2014 Dec; 32(6):2687-95. PubMed ID: 25310770
[TBL] [Abstract][Full Text] [Related]
30. The tumor suppressor role of PAQR3 in osteosarcoma.
Ma Z; Wang Y; Piao T; Li Z; Zhang H; Liu Z; Liu J
Tumour Biol; 2015 May; 36(5):3319-24. PubMed ID: 25510670
[TBL] [Abstract][Full Text] [Related]
31. Silencing of PAQR3 suppresses extracellular matrix accumulation in high glucose-stimulated human glomerular mesangial cells via PI3K/AKT signaling pathway.
Li H; Wang Y; Chen B; Shi J
Eur J Pharmacol; 2018 Aug; 832():50-55. PubMed ID: 29787774
[TBL] [Abstract][Full Text] [Related]
32. The molecular basis of CRL4DDB2/CSA ubiquitin ligase architecture, targeting, and activation.
Fischer ES; Scrima A; Böhm K; Matsumoto S; Lingaraju GM; Faty M; Yasuda T; Cavadini S; Wakasugi M; Hanaoka F; Iwai S; Gut H; Sugasawa K; Thomä NH
Cell; 2011 Nov; 147(5):1024-39. PubMed ID: 22118460
[TBL] [Abstract][Full Text] [Related]
33. Enhancement of cellular radiation sensitivity through degradation of Chk1 by the XIAP-XAF1 complex.
Kim KS; Heo JI; Choi KJ; Bae S
Cancer Biol Ther; 2014; 15(12):1622-34. PubMed ID: 25535897
[TBL] [Abstract][Full Text] [Related]
34. [Expression and Clinical Significance of Progesterone and Adiponectin Receptor Family Member 3 in Lung Cancer].
Liang X; Sun B; Han J; Zhao X; Liu Z
Zhongguo Fei Ai Za Zhi; 2017 Apr; 20(4):259-263. PubMed ID: 28442015
[TBL] [Abstract][Full Text] [Related]
35. PAQR3 plays a suppressive role in the tumorigenesis of colorectal cancers.
Wang X; Li X; Fan F; Jiao S; Wang L; Zhu L; Pan Y; Wu G; Ling ZQ; Fang J; Chen Y
Carcinogenesis; 2012 Nov; 33(11):2228-35. PubMed ID: 22828136
[TBL] [Abstract][Full Text] [Related]
36. PAQR3 augments amino acid deprivation-induced autophagy by inhibiting mTORC1 signaling.
Wang L; Pan Y; Huang M; You X; Guo F; Chen Y
Cell Signal; 2017 May; 33():98-106. PubMed ID: 28214587
[TBL] [Abstract][Full Text] [Related]
37. ANKRD9 is associated with tumor suppression as a substrate receptor subunit of ubiquitin ligase.
Lee Y; Lim B; Lee SW; Lee WR; Kim YI; Kim M; Ju H; Kim MY; Kang SJ; Song JJ; Lee JE; Kang C
Biochim Biophys Acta Mol Basis Dis; 2018 Oct; 1864(10):3145-3153. PubMed ID: 30293565
[TBL] [Abstract][Full Text] [Related]
38. X-linked intellectual disability gene CUL4B targets Jab1/CSN5 for degradation and regulates bone morphogenetic protein signaling.
He F; Lu D; Jiang B; Wang Y; Liu Q; Liu Q; Shao C; Li X; Gong Y
Biochim Biophys Acta; 2013 May; 1832(5):595-605. PubMed ID: 23357576
[TBL] [Abstract][Full Text] [Related]
39. Dynamics of DDB2-DDB1 complex under different naturally-occurring mutants in Xeroderma Pigmentosum disease.
Feltes BC; Pedebos C; Bonatto D; Verli H
Biochim Biophys Acta Gen Subj; 2018 Dec; 1862(12):2579-2589. PubMed ID: 30251654
[TBL] [Abstract][Full Text] [Related]
40. NRIP/DCAF6 stabilizes the androgen receptor protein by displacing DDB2 from the CUL4A-DDB1 E3 ligase complex in prostate cancer.
Chen HH; Fan P; Chang SW; Tsao YP; Huang HP; Chen SL
Oncotarget; 2017 Mar; 8(13):21501-21515. PubMed ID: 28212551
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
